Back to search

Peptide record

TPDB08851

Antibacterial Anticancer Antifungal Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08851
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 dbACP dbAMP 3.0 AFP-GFuse Antifungipept CAFPdb
standard
No
A 18-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KCRRYCYRQRCVTYCRGR
Physicochemical Analysis
C97H160N38O24S4
ANDEHILMFPSW
R
2370.82
10.27
7
0
4
+7
2.87
-1.400
16.11
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
4720
199.09
9
Residue Composition
number
0
A
6
R
0
N
0
D
4
C
0
E
1
Q
1
G
0
H
0
I
0
L
1
K
0
M
0
F
0
P
0
S
1
T
0
W
3
Y
1
V
Amino Acid Distribution
A: 0 R: 6 N: 0 D: 0 C: 4 E: 0 Q: 1 G: 1 H: 0 I: 0 L: 0 K: 1 M: 0 F: 0 P: 0 S: 0 T: 1 W: 0 Y: 3 V: 1
Chemical Descriptors
18
C97H160N38O24S4
2370.82
10.27
+7
2.87
-1.400
Evidence Records 4 records
Evidence 1 Activity

Activity

26.3±5.7% Hemolysis
Toxicity
64 µM
Hemolytic Cytotoxic
26.3±5.7% Hemolysis | 64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties. | ACS Chem Biol | 2017
Evidence 2 Activity

Activity

CC50
Toxicity
14.7±1.5 µM
Cytotoxic
CC50 | 14.7±1.5 | µM | target cell: Human foreskin fibroblasts (HFF)

Target

Human foreskin fibroblasts (HFF)

Source & Reference

NA
DBAASP
Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties. | ACS Chem Biol | 2017
Evidence 3 Activity

Activity

CC50
Toxicity
10.4±1.0 µM
Cytotoxic
CC50 | 10.4±1.0 | µM | target cell: Human PBMC

Target

Human PBMC

Source & Reference

NA
DBAASP
Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties. | ACS Chem Biol | 2017
Evidence 4 Activity

Activity

% Hemolysis
Toxicity
32 %
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.28741926] 20.6-32% hemolysis at 64 µM against human red blood cells | Cytotoxicity: [Ref.28741926] CC50 = 26.5 ± 2.4 µM against CRL-1739, CC50 = 2.0 ± 0.1 µM against MM96L, CC50 = 14.7 ± 1.5 µM against HFF-1, CC50 = 20.9 ± 1.4 µM against HeLa, CC50 = 15.2 ± 1.9 µM against MCF-7, CC50 = 1.3 ± 0.1 µM against K-562, CC50 = 15.7 ±1.1µM against HL-60 CC50=10.4 ± 1.0µM against PBMCs.

Target

erythrocytes

Source & Reference

NA
DRAMP
ACS Chem Biol. 2017 Sep 15 12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?